{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:09:11Z","timestamp":1789178951737,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.clim.2015.12.010","type":"journal-article","created":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T18:01:31Z","timestamp":1451325691000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Clinical heterogeneity of dominant chronic mucocutaneous candidiasis disease: presenting as treatment-resistant candidiasis and chronic lung disease"],"prefix":"10.1016","volume":"164","author":[{"given":"Laura","family":"Dotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Scomodon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Padoan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silviana","family":"Timpano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Plebani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarosa","family":"Soresina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios","family":"Lougaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Concolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Giardino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Licari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Marseglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Pignata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Tamassia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Facchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Vairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Badolato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2015.12.010_bb0005","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20110958","article-title":"Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis","volume":"208","author":"Liu","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2015.12.010_bb0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1100102","article-title":"STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis","volume":"365","author":"van de Veerdonk","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2015.12.010_bb0015","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.coi.2012.04.011","article-title":"Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes","volume":"24","author":"Boisson-Dupuis","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2015.12.010_bb0020","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.coi.2010.06.009","article-title":"Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines?","volume":"22","author":"Puel","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2015.12.010_bb0025","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/INF.0b013e3181fdff4a","article-title":"The clinical spectrum of patients with deficiency of Signal Transducer and Activator of Transcription-1","volume":"30","author":"Averbuch","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.clim.2015.12.010_bb0030","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1182\/blood-2011-01-330571","article-title":"Severe impairment of IFN-\u03b3 and IFN-\u03b1 responses in cells of a patient with a novel STAT1 splicing mutation","volume":"118","author":"Vairo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clim.2015.12.010_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.0020131","article-title":"Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease","volume":"2","author":"Chapgier","year":"2006","journal-title":"PLoS Genet."},{"key":"10.1016\/j.clim.2015.12.010_bb0040","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","article-title":"Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-\u03b3 immunity","volume":"26","author":"Bustamante","year":"2014","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.clim.2015.12.010_bb0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijcard.2015.05.183","article-title":"Recurrent inflammatory aortic aneurysms in chronic mucocutaneous candidiasis with a gain-of-function STAT1 mutation","volume":"196","author":"Tanimura","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.clim.2015.12.010_bb0050","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.jaci.2013.01.052","article-title":"Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis","volume":"131","author":"Sampaio","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2015.12.010_bb0055","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaci.2014.02.037","article-title":"Gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation-related primary immunodeficiency is associated with disseminated mucormycosis","volume":"134","author":"Kumar","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2015.12.010_bb0060","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/S0140-6736(12)60365-1","article-title":"Herpes in STAT1 gain-of-function mutation [corrected]","volume":"379","author":"T\u00f3th","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2015.12.010_bb0065","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s10875-014-0111-7","article-title":"Orf infection in a patient with Stat1 gain-of-function","volume":"35","author":"Kilic","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2015.12.010_bb0070","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jaci.2012.11.054","article-title":"Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome","volume":"131","author":"Uzel","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2015.12.010_bb0075","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jaci.2013.09.032","article-title":"Fatal combined immunodeficiency associated with heterozygous mutation in STAT1","volume":"133","author":"Sharfe","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2015.12.010_bb0080","series-title":"Clinical and Immunological Data of Nine Patients with Chronic Mucocutaneous Candidiasis Disease","author":"Dotta","year":"2015"},{"key":"10.1016\/j.clim.2015.12.010_bb0085","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s004390100505","article-title":"Nomenclature for the description of human sequence variations","volume":"109","author":"Den Dunnen","year":"2001","journal-title":"Hum. Genet."},{"key":"10.1016\/j.clim.2015.12.010_bb0090","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/nar\/11.5.1475","article-title":"Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei","volume":"11","author":"Dignam","year":"1983","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.clim.2015.12.010_bb0095","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/jmedgenet-2013-101570","article-title":"New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe","volume":"50","author":"Solt\u00e9sz","year":"2013","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.clim.2015.12.010_bb0100","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jaci.2014.12.1867","article-title":"Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation","volume":"135","author":"Higgins","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2015.12.010_bb0105","first-page":"339","article-title":"Positive expiratory pressure (PEP-mask) physiotherapy improves ventilation and reduces volume of trapped gas in cystic fibrosis","volume":"21","author":"Groth","year":"1985","journal-title":"Bull. Eur. Physiopathol. Respir."},{"key":"10.1016\/j.clim.2015.12.010_bb0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1479972309348659","article-title":"Effect of airway clearance techniques in patients experiencing an acute exacerbation of chronic obstructive pulmonary disease: a systematic review","volume":"7","author":"Hill","year":"2010","journal-title":"Chron. Respir. Dis."},{"issue":"1997","key":"10.1016\/j.clim.2015.12.010_bb0115","first-page":"1195","article-title":"Usefulness of chest physiotherapy with positive expiratory pressure (PEP)-mask in HIV-infected children with recurrent pulmonary infections","volume":"86","author":"Plebani","year":"1992","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.clim.2015.12.010_bb0120","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1164\/rccm.200708-1248OC","article-title":"Reference ranges for spirometry across all ages: a new approach","volume":"177","author":"Stanojevic","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.clim.2015.12.010_bb0125","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaci.2010.05.016","article-title":"Forced expiratory flow between 25% and 75% of vital capacity and FEV1\/forced vital capacity ratio in relation to clinical and physiological parameters in asthmatic children with normal FEV1 values","volume":"126","author":"Simon","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2015.12.010_bb0130","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/QCO.0000000000000147","article-title":"New therapeutic options for noncystic fibrosis bronchiectasis","volume":"28","author":"Yap","year":"2015","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"2014","key":"10.1016\/j.clim.2015.12.010_bb0135","first-page":"4880","article-title":"Two novel gain-of-function mutations of STAT1 responsible for chronic mucocutaneous candidiasis disease: impaired production of IL-17A and IL-22, and the presence of anti-IL-17F autoantibody, journal of immunology (Baltimore","volume":"193","author":"Yamazaki","year":"1950","journal-title":"MD"},{"key":"10.1016\/j.clim.2015.12.010_bb0140","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jaci.2013.04.018","article-title":"Continuous G-CSF therapy for isolated chronic mucocutaneous candidiasis: complete clinical remission with restoration of IL-17 secretion","volume":"132","author":"Wildbaum","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2015.12.010_bb0145","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1189\/jlb.0513250","article-title":"Simple diagnosis of STAT1 gain-of-function alleles in patients with chronic mucocutaneous candidiasis","volume":"95","author":"Mizoguchi","year":"2014","journal-title":"J. Leukoc. Biol."},{"issue":"5","key":"10.1016\/j.clim.2015.12.010_bb0150","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2014.05.044","article-title":"Gain-of-function mutations in signal transducer and activator of transcription 1 (STAT1): chronic mucocutaneous candidiasis accompanied by enamel defects and delayed dental shedding","volume":"134","author":"Frans","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2012","key":"10.1016\/j.clim.2015.12.010_bb0155","first-page":"1521","article-title":"Chronic mucocutaneous candidiasis caused by a gain-of-function mutation in the STAT1 DNA-binding domain, journal of immunology (Baltimore","volume":"189","author":"Takezaki","year":"1950","journal-title":"MD"},{"key":"10.1016\/j.clim.2015.12.010_bb0160","first-page":"7","article-title":"Type I interferonopathies: Mendelian type I interferon up-regulation","volume":"32C","author":"Crow","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2015.12.010_bb0165","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.immuni.2015.04.021","article-title":"Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases","volume":"42","author":"Oftedal","year":"2015","journal-title":"Immunity"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661615300802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661615300802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T15:02:22Z","timestamp":1537110142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661615300802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":33,"alternative-id":["S1521661615300802"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2015.12.010","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical heterogeneity of dominant chronic mucocutaneous candidiasis disease: presenting as treatment-resistant candidiasis and chronic lung disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2015.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}